Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

The Axe-Txe Complex of Enterococcus faecium Presents a Multilayered Mode of Toxin-Antitoxin Gene Expression Regulation

Abstract

Multidrug-resistant variants of human pathogens from the genus Enterococcus represent a significant health threat as leading agents of nosocomial infections. The easy acquisition of plasmid-borne genes is intimately involved in the spread of antibiotic resistance in enterococci. Toxin-antitoxin (TA) systems play a major role in both maintenance of mobile genetic elements that specify antibiotic resistance, and in bacterial persistence and virulence. Expression of toxin and antitoxin genes must be in balance as inappropriate levels of toxin can be dangerous to the host. The controlled production of toxin and antitoxin is usually achieved by transcriptional autoregulation of TA operons. One of the most prevalent TA modules in enterococcal species is axe-txe which is detected in a majority of clinical isolates. Here, we demonstrate that the axe-txe cassette presents a complex pattern of gene expression regulation. Axe-Txe cooperatively autorepress expression from a major promoter upstream of the cassette. However, an internal promoter that drives the production of a newly discovered transcript from within axe gene combined with a possible modulation in mRNA stability play important roles in the modulation of Axe:Txe ratio to ensure controlled release of the toxin.

Citation: Boss L, Labudda Ł, Węgrzyn G, Hayes F, Kędzierska B (2013) The Axe-Txe Complex of Enterococcus faecium Presents a Multilayered Mode of Toxin-Antitoxin Gene Expression Regulation. PLoS ONE 8(9): e73569. https://doi.org/10.1371/journal.pone.0073569

Editor: Nancy E Freitag, University of Illinois at Chicago College of Medicine, United States of America

Received: June 11, 2013; Accepted: July 20, 2013; Published: September 3, 2013

Copyright: © 2013 Boss et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work was supported by the Polish Ministry of Science and Higher Education (project grant no N N301 251936 to BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: Finbarr Hayes is on the Editorial Board of PLOS ONE. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Introduction

Recent analyses of the dynamics of invasive infections causing bacteraemia in European countries showed the fastest increase in the number of infections caused by Enterococcus sp. relative to other tested pathogens [1]. The treatment of infections caused by these bacteria is particularly difficult because of their intrinsic resistance to certain groups of antibiotics including penicillins, cephalosporins, and aminoglycosides. Moreover, the tendency of enterococci to acquire and exchange a wide variety of resistance determinants through horizontal transfer of mobile genetic elements such as plasmids and transposons further reduces the antibiotics available to treat certain enterococcal infections [2,3].

Molecular mechanisms responsible for the spread and stable maintenance of antibiotic resistance genes located on plasmids are well documented for model bacteria such as Escherichia coli. One of the stabilisation mechanisms that assures effective propagation of low copy number bacterial plasmids is their active segregation to daughter cells during cell division. Additionally, plasmids encode toxin-antitoxin (TA) systems that act in postsegregational killing of cells that have failed to acquire a plasmid at division [4]. In these daughter cells devoid of a plasmid, the degradation of antitoxin and the lack of its de novo synthesis leads to the release of the toxin which interacts with its intracellular target, leading to cell death or inhibition of metabolic processes. Thus, as progeny die if the plasmid is lost, bacteria become “addicted” to TA modules located on plasmids. TA complexes are also widely encoded by chromosomes of prokaryotes. Here, the toxin is activated in response to diverse stress and nutritional stimuli that result in downregulation of metabolism and/or programmed cell death. Chromosomal TAs are also implicated in antibiotic persistence, biofilm formation, and bacteriophage resistance [5].

To date, five different TA types based on the nature and mode of action of the antitoxin have been proposed [6]. Our current study focuses on type II TA systems, in which both the toxin and the antitoxin are proteins. In this group, TA modules generally have similar organizations and modes of expression regulation [5,7–9]. The cassettes usually consist of a pair of genes forming an operon. The first gene encodes a more labile antitoxin which is a target for Clp or Lon proteases, whereas the second gene specifies a stable toxin. Strong and specific interactions between toxin and antitoxin proteins, as well as precise transcriptional regulation of their expression, are characteristic feature of TA complexes. Expression of the two genes must be in balance as inappropriate levels of toxin can be dangerous to the host. The controlled production of toxin and antitoxin is achieved by transcriptional regulation of TA operons. Usually, type II TA operons are negatively autoregulated at the transcriptional level, but the detailed molecular mechanisms that underpin this process are still poorly understood for most TA modules. Nevertheless, a common pattern involves binding of the antitoxin to palindromic sequences in the promoter region by its N-terminal domain, making the antitoxin the principal factor for transcriptional repression. The C-terminal domain of the antitoxin generally binds to the toxin which acts as a co-repressor by increasing the affinity and stability of the regulatory complex. This canonical pattern of transcriptional autoregulation characterizes the best described type II TA cassettes, including YefM-YoeB, RelBE, MazEF, CcdAB and Kis-Kid [10–14]. Additionally, cooperative binding of certain TA complexes to operator DNA occurs only when toxins and antitoxins are in proper stoichiometric relationships. Excess toxin stimulates operon transcription by releasing the TA complex from the operator site which prevents uncontrolled toxin activation [15,16].

Nevertheless, some exceptions to this general pattern of type II TA regulation are known. Binding of the antitoxin alone is sufficient for full repression of the parDE TA operon on low copy number plasmid RK2 [17]. Additional genes are involved in repression of the paaR-paaA-parE and ε-ζ-ω TA systems. In the case of the PaaA antitoxin-ParE toxin complex in E. coli O157:H7, it autorepresses the main promoter only partially, but the PaaR protein is needed for full down-regulation of transcription [18]. On the other hand, in the case of the ε-ζ-ω system of plasmid pSM19035, the ζ toxin and ε antitoxin have no roles in transcriptional control. Instead, transcription of the operon is efficiently repressed solely by the ω protein [19]. Unlike its E. coli homologues, the chromosomal type II mazEF operon of Staphylococcus aureus is not autoregulated. Instead, the global transcriptional regulator SarA activates the cassette, whereas the alternative sigma factor σB represses its transcription, probably indirectly [20].

As TAs are key for both maintenance of mobile genetic elements that specify antibiotic resistance and in bacterial persistence and virulence, dissection of these systems in pathogenic bacteria, including enterococci, is crucial [21]. Par and Axe-Txe encoded by plasmids of Enterococcus faecalis and E. faecium, respectively, were among the first TA systems identified in enterococci [22–24]. The par locus specifies two small RNA molecules, RNA I and RNA II. The former is translated into a 33 amino acid toxic peptide whose expression is regulated posttranscriptionally by RNA II [25]. Differential decay patterns of RNA I and RNA II elicit translation of the former in plasmid-free cells. The toxin disrupts cell membrane function by an as yet unknown mechanism [26].

The type II axe-txe module was first identified on the multidrug resistant pRUM plasmid from a clinical isolate of E. faecium. Axe-Txe is a plasmid maintenance complex not only in enterococci, but also in evolutionary diverged species, including Bacillus sp. and E. coli. Axe-Txe is homologous to the YefM-YoeB complex of E. coli [24]. Txe (85 amino acids) is a positively charged toxin that is neutralized by Axe (89 amino acids), a negatively charged antidote. When liberated from the complex, Txe acts as an endoribonuclease that cleaves cellular mRNA downstream of AUG start codons [27]. Txe thereby inhibits bacterial growth and cell division [24]. Axe-Txe and certain other TA modules are found widely in antibiotic resistant enterococci, including vancomycin resistant isolates [28–30].

In this study, we investigated mechanisms underpinning regulation and expression control of the axe-txe module. Our studies show that the expression of axe-txe genes is different than in other described TA systems. Notably, an internal promoter that drives the production of a novel transcript was detected within the axe gene. This message, together with mRNA stability control, may be a part of a complex regulatory circuit that tunes the ratio of Axe antitoxin to Txe toxin.

Materials and Methods

Strains

E. coli DH5α was used for plasmid construction and Rosetta(DE3) for crude extract preparation with Axe and Axe-Txe overproduction from pET22axe and pET22at_axe-txe, respectively. Strain SC301467 [31] was used for DNA and RNA isolation and for luminescence assays, and C600polA1 was used in plasmid stability assays. Bacteria were grown in Luria-Bertani (LB) medium at 37°C. Ampicillin and chloramphenicol were added to final concentrations of 100 and 34 or 10 µg/ml, respectively, when required.

Plasmids and oligonucleotides

Oligonucleotides and plasmids used in this study are listed in Tables 1 and 2, respectively.

OligonucleotideSequence (5’–3’)
1GACGAATTCTACAATTTCAGGTGGCAC
2GGTGAATTCGTAAACTTGGTCTGACAG
3CCGATTACATATGGAAGCAGTAGCTTATTC
4GACTCGAGATCATCAGATTCAACCTCG
5TTCAGGATCCAGGATTATGTGTATTGCG
6CCGCAAGCTTTTAAGTTTCTGACCCTTTCC
7GAGTACTAGTGAAAAAGCAGGATTTGAGG
8CCAAGGATCCGAATAAGCTACTGCTTCC
9CGGTCGGATCCAATAAAGATAATCATC
10ATTCGGATCCTTAATAGTGATCTTTTGCAG
11CGGGACTAGTTAGAAATAAATAAGGGGT
12CAAAAAGAGATTACGACTCTATGCAAGAAACG
13CGTTTCTTGCATAGAGTCGTAATCTTTTTTG
14CGCGGGAATTCTAGAAATAAATAAGGGGT
15GCACTAAATCATCACTTTCGGGAAAG
16GAGTGAATTCGAAAAAGCAGGATTTGAGG
17ATCGGATCCGTAATACGCGTAAC
18CCGCAAGCTTGCTCATGCCAATAAAGATAATC
19[BTN]AGCAACTAAAGCAGAAGTACGGC
20TCATATAACTACGTAAATTTTGGCGG
21[BTN]TTCCGCCAAAATTTACGTAGTTA
22TTGCATAGAATCATAATCTCTTTTTGA

Table 1. Oligonucleotides used in this study.

Restriction sites or introduced mutations are underlined.
CSV
Download CSV
NameDescriptionReference
pBBRluxVector for generating transcriptional fusion to lux, Cmr [32]
pBBRlux-ampVector for generating transcriptional fusion to lux, bla gene was amplified with primers 1/2 and cloned into EcoRI site within cat geneThis study
pET22b(+)IPTG-inducible expression vector allowing fusion of C-terminal His6 tag to the target protein, AmpRNovagen
pET22axeaxe gene amplified with primers 3/4, digested with NdeI-XhoI and cloned between equivalent sites in pET22(+)This study
pET22at_axe-txeat_axe-txe fragment amplified with primers 5/6, digested with BamHI-HindIII and cloned between equivalent sites in pET22(+)This study
pluxatpat promoter-operator region amplified with primers 7/8 (209 bp), digested with SpeI-BamHI and cloned between equivalent sites in pBBRlux-ampThis study
pluxat_axefragment containing pat promoter-operator region and axe gene amplified with primers 7/9 (497 bp), digested with SpeI-BamHI and cloned between equivalent sites in pBBRlux-ampThis study
pluxat_axe-txefragment containing pat promoter-operator region and axe-txe genes amplified with primers 7/10 (708 bp), digested with SpeI-BamHI and cloned between equivalent sites in pBBRlux-ampThis study
pluxaxepaxe promoter-operator region amplified with primers 9/11 (353 bp), digested with SpeI-BamHI and cloned between equivalent sites in pBBRlux-ampThis study
pluxaxemutpaxe promoter-operator region with mutated -10 box (site-directed mutagenesis with primers 12/13) amplified with primers 9/11 (353 bp), digested with SpeI-BamHI and cloned between equivalent sites in pBBRlux-ampThis study
pluxaxe-txeW5Caxe-txe genes with amino acid change in Txe protein (W5C) amplified with primers 10/11 (564 bp), digested with SpeI-BamHI and cloned between equivalent sites in pBBRlux-ampThis study
pREG531pFH450 derivative plasmid containing axe-txe cassette, used for amplifications of this module and plasmid stability tests, Cmr [24]
pREGpaxemutpREG531 derivative with paxe promoter-operator region mutated in -10 box (site-directed mutagenesis with primers 12/13)This study
pREGΔaxetxepREG531 derivative, where axe-txe cassette was cut out with enzymes KpnI and SpeI and vector was religatedThis study
pTE103Vector for generating transcription templates, contains the multicloning site from pUC8 placed upstream from a bacteriophage T7 transcriptional terminator, AmpR [33]
pTEat_axetxefragment containing pat promoter-operator region and axe-txe genes amplified with primers 6/16, digested with EcoRI-HindIII and cloned between equivalent sites in pTE103This study
pTEat_axetxemutfragment containing pat promoter-operator region and axe-txe genes with mutated -10 box in paxe promoter amplified with primers 6/16, digested with EcoRI-HindIII and cloned between equivalent sites in pTE103This study
pTEaxetxeW5Caxe-txe genes with amino acid change in Txe protein (W5C) amplified with primers 6/14, digested with EcoRI-HindIII and cloned between equivalent sites in pTE103This study
pTEaxeaxe and first 60 bp of txe genes amplified with primers 14/18, digested with EcoRI-HindIII and cloned between equivalent sites in pTE103This study
pTEat_axe-txe_terfragment containing pat promoter-operator region and axe-txe genes along with the terminator region downstream of txe, amplified with primers 16/17, digested with EcoRI-BamHI and cloned between equivalent sites in pTE103This study

Table 2. Plasmids used in this study.

CSV
Download CSV

Crude extract preparation

Bacteria were grown at 37°C in 10 ml of LB medium with appropriate antibiotic until OD600 ~0.5. Expression of axe (pET22axe) or axe-txe (pET22at_axe-txe) was induced with 1 mM IPTG and incubation continued for 3 hours. Cells were harvested at 1600 g for 10 min. The pellet was resuspended in 1 ml of buffer comprising 20 mM Tris–HCl pH 7.5 and 50 mM NaCl. The cells were sonicated and then centrifuged for 30 min at 15500 g at 4oC. Supernatant was dialysed against the same buffer containing 10% glycerol. The samples were aliquoted and stored at -20oC.

Promoter fusion studies and bioluminescence assays

Strain SC301467 harbouring derivatives of pBBRlux-amp with the lux operon under transcriptional control of fragments containing different elements of axe-txe operon were used. PCR fragments were cloned into pBBRlux-amp between SpeI-BamHI restriction sites upstream of the promoterless luxCDABE to yield the transcriptional fusions pat::lux (primers 7/8), pataxe::lux (primers 5/7), pataxe-txe::lux (primers 7/10), paxe::lux (primers 9/11) and paxemut::lux (primers 9/11). Overnight cultures carrying recombinant plasmids were diluted (1:100) into fresh LB medium and grown until OD600 ~0.4. Then luminescence of 200 µl of cells was measured in a luminometer (Berthold Technologies, Junior). Results in relative light units (RLU) were divided by the optical density (OD600) of the cultures.

Plasmid stability assays

The bacteria containing different constructs were grown under selective conditions overnight. 10 µl of the resulting culture were used to inoculate 10 ml of fresh medium again with antibiotic pressure and left to grow with shaking for 12 hours. Next, 1/10000 dilutions were made every 12±3 hours in fresh medium without selective pressure. Successive subcultures were repeated 5 times in total. Samples from each subculture were plated on LB agar without antibiotic to obtain single colonies. For determination of plasmid stability one hundred colonies of each strain were streaked on LB agar plates supplemented with chloramphenicol and, as a control, to LB agar plates containing no antibiotic. The retention of chloramphenicol-resistance phenotype was shown as a percentage.

Primer extension analysis

The promoters in the axe-txe cassette region were mapped with a 32P-labeled primer (primer 15) that anneals to the lux gene downstream from the region of interest. Total cellular RNA from strain SC301467 harbouring pBBRlux–based plasmids possessing transcriptional fusions of pat or paxe promoter-operator regions to the lux operon (pluxat or pluxaxe) were combined with the labeled primer. Primer extension reactions were done in total volumes of 10 µl containing 10 µg RNA, 0.6 pmol of labeled primer, RevertAid H Minus Reverse Transcriptase buffer (50 mM Tris-HCl pH 8.3, 50 mM KCl, 4 mM MgCl2, 10 mM DTT), 1 mM of each dNTPs, 10 U RiboLock RNase Inhibitor. Samples were denatured at 990C for 2 min, and then incubated at 500C for 1 hour. Next, 0.5 µl of 200 U/µl RevertAid H Minus Reverse Transcriptase (Fermentas) were added and samples were incubated at 420C for 30 min. 5 µl of loading dye (95% formamide, 0.05% bromophenol blue, 0.05% xylene cyanol) were added and samples were denatured for 10 min at 990C prior loading on a 6% sequencing gel along with sequencing reactions performed with the same labeled primer and appropriate plasmid DNA (SequiTherm EXCEL™ II DNA Sequencing Kit, Epicenter) according to the protocol.

Electrophoretic mobility shift assays (EMSA)

5’-biotinylated, double-stranded PCR fragments that included the pat (primers 19/20) and paxe (primers 21/22) regulatory regions were used in EMSA. Reactions containing 0.1 nM of biotin–labeled DNA and bacterial crude extract at concentrations of 0, 1.25, 2.5, 5, 10, 12.5 and 25 µg/ml total protein were assembled in binding buffer (10 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM DTT, 5 mM MgCl2, 1 µg of poly(dIdC), 2.5% glycerol) in final volumes of 20 µl and incubated for 20 min at 22°C. Then samples were electrophoresed on 6% native polyacrylamide gels in 0.5x TBE buffer for 120 min at 100V at 4°C. DNA was transferred by electroblotting to positively–charged nylon membrane (Millipore), and the transferred DNA fragments were immobilized onto the membrane by ultraviolet cross-linking. Detection of the biotin–labeled DNA was performed using the LightShiftTM chemiluminescent EMSA kit (Pierce).

In vitro transcription analysis

Transcription activity within the axe-txe operon was analysed in multiround in vitro transcription assays performed on circular plasmid DNAs (derivatives of pTE103 vector) as indicated on figures. Reactions were done at 370C in total volumes of 17 µl containing 40 mM Tris-HCl pH 8.0, 150 mM KCl, 10 mM MgCl2, 10 mM DTT, 17 U RiboLock RNase Inhibitor, 0.1% β-mercaptoethanol and 0.025 U inorganic pyrophosphatase (Ppase). E. coli σ70 RNA polymerase holoenzyme (RNAP) was added and samples were incubated for 7 min following which 5 nM DNA was added for another 7 min. Next, 0.15 mM of GTP, ATP and CTP, 0.015 mM of UTP and 0.8 µCi α32P-UTP were added and reactions were run for 15 min. 17 µl of stop solution (95% formamide, 0.5 M EDTA, 0.05% bromophenol blue) were added and samples were denatured for 10 min at 950C prior to loading on a 6% polyacrylamide gel.

Bioinformatics

Promoter searches were performed using PromScan bioinformatic program (http://molbiol-tools.ca/promscan/). Terminator hairpin was predicted and drawn using MFOLD program (http://mfold.rna.albany.edu/).

Results

pat promoter activity is inhibited by the Axe-Txe protein complex

Type II TA genes generally are organized in operons and their expression is negatively regulated at the transcriptional level by action of antitoxin alone or in complex with its toxin partner. To assess whether the axe-txe genes show a similar scheme of regulation, primer extension analysis was first performed to determine the transcription start point(s) of the pat promoter. Because it has been shown that the axe-txe system is fully functional as a stability cassette in E. coli [24], we performed experiments in this bacterium. A single major primer extension product was detected (Figure 1B). Sequences with close matches to consensus -10 (5/6 matches) and -35 (3/6 matches) boxes separated by an optimal 17 bp are located 5’ of this transcription start site (Figure 1A). In addition, a sequence resembling the ribosome binding site (5’-AAGGGG-3’) located 8 nt upstream of the axe start codon was observed (Figure 1A).

thumbnail
Download:
Figure 1. Pat promoter sequence and activity.

(A) Nucleotide sequence of the pat region. The transcription start site mapped by primer extension is marked by a vertical arrow. -10 and -35 promoter motifs are underlined and the axe start codon is in bold. Palindromes potentially recognised by Axe-Txe are denoted by inverted horizontal arrows. (B) Primer extension analysis of axe-txe module. Total RNA from E. coli SC301467 cells harbouring a plasmid possessing the axe-txe operon was subjected to primer extension analysis (E) using a radioactively labelled primer that anneals within flanking vector sequences. Reactions were performed and analysed as outlined in Materials and Methods, and electrophoresed on a denaturing 6% polyacrylamide gel in parallel with nucleotide sequencing reactions (A, C, G, T) carried out with the same primer. The major product from the primer extension is marked as +1. (C) Autoregulation of axe-txe expression by Axe and Axe-Txe in cis. Transcriptional fusions of different fragments of the axe-txe operon to the luxCDABE operon in pBBRlux-amp plasmid were transformed into E. coli SC301467. Luminescence in RLU (relative luminescence units) was measured when cells obtained OD600 ~0.4. The results are averages of at least three independent experiments.

https://doi.org/10.1371/journal.pone.0073569.g001

To assess the influence of Axe and Txe proteins on pat promoter activity, in vivo and in vitro tests were performed. A fragment encompassing the pat promoter and axe start codon was inserted upstream of a promoterless lux operon in the transcription fusion vector pBBRlux-amp and established in strain SC301467, which is deleted of five chromosomal toxin-antitoxin cassettes [31] to reduce any possible cross interactions from E. coli chromosomal TA cassettes, including the yefM-yoeB system which is homologous to axe-txe. This fusion produced ~7 x 106 RLU, whereas pBBRlux-amp alone produced ~100 units (Figure 1C, bars a and b). Thus, the region 5’ of axe-txe possesses a strong promoter activity. In fact, cloning this region upstream of the lac operon in different vectors was unsuccessful, generating mutations in the promoter sequence which is a feature characteristic of very strong promoters. To compare the strength of pat, a related promoter of the yefM-yoeB system of E. coli [10,34] was also cloned upstream of the promoterless lux operon in the same vector. This construct produced ~3.5 x 105 RLU. Thus, pat appears to be a particularly strong promoter.

The 3’ end of axe overlaps the 5’ end of txe by 8 nt. We aimed to examine the influence of Axe and Txe on pat activity in trans by cloning these overlapping genes under several different arabinose- or IPTG-inducible promoters. Despite many trials, we were not able to clone these genes (data not shown). As an alternative, it was decided to construct in cis fusions in which the pat promoter, followed by axe or axe-txe genes, was fused to the lux operon. In this system, Axe alone inhibited pat weakly (Figure 1C, bar c) whereas an ~5-fold decrease in pat activity was observed in the presence of the Axe-Txe complex (Figure 1C, bar d).

Sequence analysis of the pat promoter region previously revealed two inverted 5’-TGTACA-3’ repeats that are identical to those present in the promoter of the homologous yefM-yoeB module and which are responsible for binding the toxin-antitoxin complex [10,34]. Moreover, in the case of pat, these repeats are additionally organized as a more extended inverted repeat with a single mismatch (Figure 1A). These sequences are candidate contact sites for the putative DNA binding N-terminal domain of the Axe antitoxin. To test the affinity of Axe and the Axe-Txe complex for binding to the promoter region in vitro, EMSA experiments were performed. For these experiments, BL21(DE3) crude extracts with overproduced Axe or Axe-Txe complex from the pET22(b) vector were used. BL21, like other E. coli B strains, does not possess the chromosomal yefM-yoeB cassette, thus any potential cross-talk between these two homologous systems can be excluded [35]. Note that cloning of the axe-txe genes under the pT7 promoter was possible only if the pat promoter was included. A 295 bp biotin-labeled fragment containing the promoter region was incubated with different concentrations of crude extracts. Axe alone bound to the promoter fragment only at high extract concentrations (Figure 2B), whereas the Axe-Txe complex retarded migration of the target fragment at lower concentrations of extract, producing one major shifted species (Figure 2C). An extract lacking both proteins did not retard the promoter fragment (Figure 2A). In summary, in vivo and in vitro experiments indicate that Axe has a weak affinity to the pat promoter region. In contrast, the Axe-Txe complex binds pat efficiently in vitro and also represses the promoter more effectively than Axe in vivo, although this negative regulation of axe-txe transcription may be less effective than in other TA systems.

thumbnail
Download:
Figure 2. Axe and Axe-Txe binding to the pat promoter-operator region.

A 295-bp 5’ biotinylated fragment that included the axe translation start codon and upstream promoter-operator region was subjected to EMSA. The fragment was incubated with different concentrations of E. coli BL21(DE3) crude extracts (left to right in each panel): 0, 1.25, 2.5, 5, 10, 12.5 and 25 µg/ml. Reactions were incubated for 20 min at 220C, analyzed by native 5% PAGE, and processed further as outlined in Materials and Methods. (A) no Axe or Txe produced; (B) Axe overproduction; (C) Axe-Txe overproduction. Filled and open arrows denote positions of unbound DNA and protein-DNA complexes, respectively.

https://doi.org/10.1371/journal.pone.0073569.g002

An active promoter which contributes to Txe toxicity is located within the axe gene

The inability to clone the axe-txe cassette under control of an inducible promoter suggested that regulatory elements additional to pat might be present in this region. Searches using the PromScan program revealed the presence of a putative promoter within axe that might be implicated in expression of the downstream txe gene. A fragment of the axe gene encompassing this region was fused transcriptionally to the lux operon. This fusion produced >3 x 105 RLU confirming the existence of a substantial promoter activity (paxe) within the axe coding sequence that might drive expression of txe (Figure 3C). This activity was comparable with that obtained for the strong yefM-yoeB promoter described above.

thumbnail
Download:
Figure 3. Paxe promoter sequence and activity.

(A) Nucleotide sequence of the paxe region. The transcription start site mapped by primer extension is marked by a vertical arrow. -10 and -35 promoter motifs are underlined and the txe start codon is in bold. (B) Primer extension analysis of paxe. Total RNA from E. coli SC301467 cells harbouring a plasmid possessing the axe gene was subjected to primer extension analysis (E) using a radioactively labelled primer that anneals within flanking vector sequences. Reactions were performed and analysed as outlined in Materials and Methods, and electrophoresed on a denaturing 6% polyacrylamide gel in parallel with nucleotide sequencing reactions (A, C, G, T) carried out with the same primer. The major product from the primer extension is marked as +1. (C) A transcriptional fusion of the axe gene to the luxCDABE operon in pBBRlux-amp plasmid (paxe_lux) was transformed into E. coli SC301467 and luminescence in RLU (relative luminescence units) determined. paxemut_lux denotes a construct in which paxe possesses two substitution mutations in the -10 box (see text). The results are the averages of at least three independent experiments.

https://doi.org/10.1371/journal.pone.0073569.g003

Primer extension experiments determined the transcription start point of paxe (Figure 3B). Sequences with close matches to consensus -10 (5/6 matches) and -35 (3/6 matches) motifs, separated by an optimal 17 bp, are located 5’ of the transcription start site which lies ~110 bp upstream of the translation start codon for the Txe toxin (Figure 3A). To determine if the assigned promoter was responsible for the significant expression observed in the lux transcriptional reporter fusion, mutations were introduced into the -10 sequence (TATGAT->TACGAC) and the mutated sequence (paxemut) was inserted upstream of lux. The mutations almost entirely abolished lux expression confirming the assignment of paxe (Figure 3C). EMSA experiments showed that neither the Axe-Txe proteins nor other proteins in the E. coli extract bound detectably to a fragment bearing the wild-type paxe promoter (Figure S1).

The presence of the paxe promoter internal to the axe gene may explain the inability to clone the axe-txe cassette under a heterologous promoter: the balance between axe and txe expression may be altered when pat is replaced by a different promoter. However, cloning of the axe-txe cassette was possible when the pat promoter was retained at its normal location. Nevertheless, this construct (pTEpat_axe-txe) inhibited bacterial growth, indicating that axe-txe expression was also perturbed (Figure 4). Evidence that paxe drives the synthesis of Txe was provided by experiments with a strain bearing a plasmid in which the entire axe-txe cassette, including the pat promoter, was again cloned, but in which paxe carried the -10 box mutations described above (pTEpat_axemut-txe). These mutations do not change the amino acid sequence of Axe. The growth profile of the strain bearing this plasmid was very similar to strains with either the vector alone or with a plasmid producing a nontoxic version of Txe which also alleviated toxicity (pTEaxe-txeW5C) (Figure 4). Thus, the paxe promoter is critical for the toxicity phenotype in this test suggesting that this internal promoter within axe is required for txe expression.

thumbnail
Download:
Figure 4. Evidence that paxe drives the synthesis of Txe toxin.

E. coli SC301467 harbouring derivatives of pTE103 bearing either the intact axe-txe module (pTEpat_axe-txe), this cassette in which paxe was mutated (pTEpat_axemut-txe), or this module producing a nontoxic version of Txe (pTEaxe-txeW5C) were grown at 370C. Absorbance readings at 600 nm were taken at 60 minutes intervals.

https://doi.org/10.1371/journal.pone.0073569.g004

As described above, in cis fusions in which the pat promoter followed by axe or axe-txe was fused to the lux operon were used to assess repression of this promoter by Axe and Axe-Txe. The data showed that pat is down-regulated weakly by Axe and more fully by the Axe-Txe complex, although not to basal levels (Figure 1C). To examine any contribution from paxe in this system, in cis fusions were designed in which this promoter was inactivated by the TATGAT->TACGAC mutations in its -10 box. Reporter data showed that expression levels of pat in the presence of either Axe alone or Axe-Txe were lower in comparison to those when paxe is intact (Figure 1C, bars e and f compared to bars c and d). Thus, paxe contributes significantly to expression levels when wild-type axe or axe-txe is fused to the lux operon, but this expression may not be subject to Axe-Txe regulation. These results also demonstrate that enough txe is expressed from pat alone to produce sufficient levels of Axe-Txe complex for repression of the in cis fusion in which paxe is mutated.

Active paxe promoter is necessary for proper functioning of the axe-txe cassette as a plasmid stabilization module

The major role of toxin-antitoxin cassettes located on plasmid DNA is stable maintenance of these mobile genetic elements in bacterial populations through a post-segregational killing mechanism. Previously, the axe-txe cassette was shown to be a functional plasmid stabilization system in evolutionary diverse bacterial hosts, including E. coli [24]. To determine whether the active paxe promoter is necessary for correct functioning of axe-txe as a plasmid stabilization module, derivatives of the segregational stability probe vector pFH450 were used [36]. This plasmid contains both moderate-copy-number ColE1 ori and low-copy-number P1 plasmid ori. However, replication of pFH450 proceeds only from the latter in a polA host. As the vector contains no accessory stabilization sequences, it is unstable in this host. Plasmid pREG531 that contains axe-txe genes and flanking sequences cloned into pFH450 was used as a positive control [24]. Changes that inactivated the paxe promoter without altering the Axe amino acid sequence (TATGAT->TACGAC) were introduced by site-directed mutagenesis producing pREGpaxemut. For the negative control, the axe-txe cassette was deleted from pREG531 to produce pREGΔaxetxe. In the absence of antibiotic selective pressure, faster plasmid loss was observed in E. coli C600polA1 bearing pREGpaxemut relative to the strain bearing pREG531 with the wild-type axe-txe module (Figure 5). Finally, after 60 hours of discontinuous growth in the absence of selection, plasmid retention for the vector possessing the intact axe-txe module was ~55%, whereas the level of plasmid retention was only ~17% for the variant in which the paxe promoter was inactivated (Figure 5). These results clearly show that the active paxe is essential for appropriate functioning of the axe-txe cassette in stable plasmid maintenance.

thumbnail
Download:
Figure 5. An active paxe promoter is required for axe-txe mediated stable plasmid maintenance.

Stability assays were conducted with derivatives of the stability probe vector, pFH450: pREGΔaxe-txe does not contain any accessory stability determinants (circles), pREG531 contains the axe-txe cassette (squares), and pREGpaxemut contains the axe-txe cassette with a mutated paxe promoter (triangles). Assays were performed as outlined in Materials and Methods. Results are averages of at least five experiments for which the standard deviation did not exceed 15%.

https://doi.org/10.1371/journal.pone.0073569.g005

Additional elements within the cassette may influence regulation of axe-txe expression

In vitro transcription analysis of the cassette was performed in the search for regulatory elements that potentially influence expression of the axe-txe operon. For this purpose pTE103 plasmid derivatives which contain a strong T7 early transcriptional terminator region were used. Thus, transcripts terminate ~280 bp downstream of the cloned fragments. Transcripts of ~850 and ~680 nt were detected that correspond to those expected to be produced from the pat and paxe promoters, respectively (Figure 6, lane 2). Mutation of the -10 box in paxe abolished production of the smaller transcript which correlates with data presented above that paxe is a bona fide promoter that is required for txe expression (Figure 6, lane 1). In addition, these in vitro transcription experiments unexpectedly revealed the presence of a third transcript (~300 nt) which appeared only when the whole txe gene fragment was present (Figure 6, lanes 1 and 2), but not when a construct with a truncated txe gene was employed (Figure 6, lane 3). These observations suggest that this transcript must originate within the txe gene.

thumbnail
Download:
Figure 6. Transcription activity within the axe-txe operon.

Multi-round in vitro transcription experiments were performed using E. coli σ70 RNA polymerase holoenzyme and pTE103 template DNA containing the whole axe-txe operon fragment (2), the same fragment but with the paxe promoter mutated (1), or the fragment with the axe gene and first 60 base pairs of the txe gene (3). The band marked as ptxe corresponds to the transcript which derives from as yet unidentified ptxe promoter. Reactions were performed and analysed as outlined in Materials and Methods. Transcript sizes were estimated according to an RNA ladder (RiboRuler Low Range RNA Ladder – Thermo Scientific) which was electrophoresed with the reactions and then excised and stained with ethidium bromide.

https://doi.org/10.1371/journal.pone.0073569.g006

Comparison of cultures harbouring plasmid pTE103 containing either the complete axe-txe module (pTEpat_axe-txe) or this module with a longer downstream sequence (pTEpat_axe-txe-ter) revealed significant growth differences (Figure 7A). In the first construct, the region downstream of txe comprises ~30-bp after the stop codon. In the second construct ~90-bp longer fragment was included. As observed previously (Figure 4), the construct with short downstream sequences partially inhibited growth due to the expression of txe from pat and paxe promoters. However, addition of the extended fragment downstream of txe alleviated this toxic effect (Figure 7A). Analysis of the sequence revealed the presence of a lengthy transcription terminator-like region starting ~20 bp downstream of the txe gene (Figure 7B). In vitro transcription assays with constructs bearing the axe-txe cassette with this stem-loop fragment showed that it functions as a transcriptional terminator/attenuator in vitro. Some of the transcripts deriving from pat as well as from paxe promoters stop at this point, while the rest terminate further at the T7 strong terminator located within the vector (Figure 8, lane 3). This putative hairpin structure may have a role in transcript stability if it is recognized by RNases that decrease the stability of the mRNAs and thereby modulate Txe production. This hypothesis is being tested currently. Moreover, the axe-txe cassette without this potential terminator region cloned into a stability probe vector clearly showed impaired activity as a stability determinant indicating the importance of this element, possibly to ensure an optimal stoichiometry between toxin and antitoxin (unpublished data).

thumbnail
Download:
Figure 7. The role of a putative terminator region downstream of the txe gene.

(A) E. coli SC301467 harbouring derivatives of pTE103 bearing the axe-txe cassette with (pat_axe-txe_ter) or without (pat_axe-txe) the putative downstream transcription terminator were grown at 370C. Absorbance readings at 600 nm were taken at 60 minutes intervals. (B) The terminator in the region downstream of the txe gene was predicted and drawn by the MFOLD program.

https://doi.org/10.1371/journal.pone.0073569.g007

thumbnail
Download:
Figure 8. A fragment downstream of txe acts as a putative transcriptional terminator/attenuator in vitro.

Multi-round in vitro transcription experiments were performed using E. coli σ70 RNA polymerase holoenzyme and pTE103 template DNAs containing the whole axe-txe operon fragment (1), the same fragment but with the paxe promoter mutated (2), or the whole axe-txe operon fragment plus the downstream putative terminator region (3). Reactions were performed and analysed as outlined in Materials and Methods. Transcript sizes were estimated according to an RNA ladder (RiboRuler Low Range RNA Ladder – Thermo Scientific) which was electrophoresed with the reactions and then excised and stained with ethidium bromide. Positions corresponding to the RNA ladder bands are marked at the right site of the autoradiogram (L). Sizes and schematic representation of the transcripts with the terminator hairpins (“peaks”) are drawn on the left site of the figure.

https://doi.org/10.1371/journal.pone.0073569.g008

Discussion

The toxin components of TA systems are intracellular molecular time bombs whose release from complexes with their cognate antitoxins can trigger bacterial programmed cell death or cell cycle arrest [5]. Understanding the mechanisms by which expression and activation of these modules are controlled is crucial to dissect their functioning and possible practical exploitation.

The Axe-Txe system was first discovered on the multidrug-resistant pRUM plasmid in a clinical isolate of E. faecium [24]. Preliminary analysis of Axe–Txe demonstrated that it functions as a characteristic TA system: expression of Txe is toxic to cells, Axe alleviates Txe-induced toxicity, and Axe–Txe increases plasmid maintenance [24]. It was also demonstrated that Txe is an endoribonuclease which cleaves mRNA and thereby inhibits protein synthesis [27]. Due to the prevalence of the axe–txe genes on plasmids in enterococcal isolates [29,30], artificial activation of Txe presents an attractive antimicrobial strategy. However, a complete lack of knowledge about regulation of axe-txe expression blocks potential exploration of the complex as an antimicrobial target.

The chromosomal yefM-yoeB toxin-antitoxin module of E. coli is homologous to axe-txe [24]. As is the case with most known TA systems, expression of yefM-yoeB is negatively autoregulated, with YefM being the primary transcriptional repressor and YoeB acting as a repression enhancer [10]. DNA binding is achieved by the sequential association of YefM with a pair of inverted repeats that comprise the yefM-yoeB operator site [10]. This interaction involves a pair of arginine residues in a unique DNA binding fold within the N-terminal region of the protein [34,35]. The YoeB toxin acts as a corepressor by stabilizing the flexible C-terminal region of YefM which also conceals the toxin’s endoribonuclease fold [35].

Analysis of the nucleotide sequence of the pat promoter-operator region upstream of axe-txe revealed two inverted repeats with the same 5’-TGTACA-3’ core that overlap the yefM-yoeB promoter [10]. In the case of pat, the repression by antitoxin alone was very weak (<2-fold), whereas the Axe-Txe complex repressed more efficiently (~5-fold). However, the activity of the pat-lux fusion remained very high in the repressed state. These results suggested that there might be another mechanism(s) which shut downs axe-txe expression. In agreement, an additional promoter (paxe) within the axe gene directs extra synthesis of Txe protein. However, this promoter lacks overlapping 5’-TGTACA-3’ boxes, is not repressed by Axe-Txe, and no detectable binding to this region was observed by Axe-Txe in vitro. The paxe promoter instead may be regulated by an unknown factor(s), or may be expressed constitutively. The ~300-nt transcript produced by the axe-txe cassette may also be implicated in controlling expression of the paxe promoter by an unknown mechanism. Nevertheless, the data clearly show that the active paxe promoter is indispensable for proper functioning of the axe-txe cassette as a plasmid stabilization module.

The control of the synthesis of most, if not all, toxin proteins of TA complexes is likely to be multilayered. Further indications that axe-txe may be subject to additional levels of regulation came from experiments with fragments containing the axe-txe cassette but with different lengths of downstream sequence. Constructs possessing an extended fragment downstream of txe that contains a putative terminator region do not inhibit bacterial growth, whereas constructs which lack this fragment exert a pronounced growth defect. One can speculate that the potential termination hairpin may serve as an element that decreases mRNA stability and in this way lowers production of the Txe toxin. mRNA stability is one of the parameters that determine the efficiency of gene expression. mRNA turnover is mediated by a combination of endo- and exoribonucleases whose activities are modulated by structural features of the mRNA [37]. One such example is the kis-kid toxin-antitoxin system in which the intracellular levels of Kis and Kid proteins are controlled by limited degradation of a polycistronic messenger. However, in this case the presence of a stem-loop sequence located within the 5’ region of kid gene shows a stabilizing effect mediated on mRNA [38]. The majority of RNA molecules are subjected to regulation and, as is the case of mRNA, their decay can be influenced by growth conditions. Moreover, the RNA degradosome can undergo changes in composition depending on growth or stress conditions [39–41].

In the case of axe-txe different regulatory mechanisms might exist to ensure a balanced production of the antitoxin relative to the toxin which is necessary for appropriate functioning of this system. The kis-kid and ccdAB operons are tightly regulated by the ratio of the toxin and the antitoxin [13,14]. It is possible that in the reporter system used here, in which the axe-txe operon lacking the terminator-like sequence downstream of txe was fused with the lux gene, the ratio of Axe and Txe was not optimal for full repression of pat promoter due to the excess of the toxin arising from altered mRNA stability. This agrees with other data showing that an excess of toxin can abolish transcriptional repression by releasing the TA complex from the operator site [15,16].

It should be emphasized that observations about axe-txe regulation presented in this paper are true for E. coli and may differ in the natural host, E. faecium. On the other hand, study of TA systems that derive from different bacterial species, including Streptococcus, Staphylococcus, Synechocystis, Streptomyces and Vibrio, in an E. coli model is common [42–46]. Nevertheless, studies of axe-txe regulation in the natural host will reveal whether different regulatory mechanisms operate in E. faecium compared to E. coli.

In conclusion, the data presented here show that the regulation of expression of the axe-txe module appears to be very complex. The pat promoter activity is very high and is only partially repressed by the concerted action of the Axe-Txe complex. Moreover, another promoter, paxe, provides additional expression of the txe gene. Therefore, the expression of the toxin gene requires additional negative regulation. This may be achieved by two means: (i) decreased stability of txe mRNA due to its degradation starting after formation of a specific hairpin structure at the 3’ end of the transcript; and (ii) the action of a counter transcript derived from the promoter located within txe gene. Our experiments clearly indicate that both the active paxe promoter and the region downstream of txe gene with the putative terminator region are necessary for proper functioning and tight regulation of the axe-txe cassette.

One might ask why did such a complicated regulatory system evolve in the axe-txe module? We speculate that additional regulatory elements provide more possibilities to optimize toxin and antitoxin production under diverse environmental conditions, e.g., nutrient availability or different temperatures. This may be especially important for bacteria living under conditions with potentially rapid fluctuations, including enterococci occupying the mammalian intestine that are suddenly excreted outside their host in stools. The balance between the amounts of toxin and antitoxin is of particular importance for cell survival.

Supporting Information

Figure S1.

Neither Axe-Txe proteins nor other proteins in the E. coli extract bound detectably to a fragment bearing the wild-type paxe promoter. A 126 bp 5’ biotinylated fragment that includes paxe was subjected to EMSA. DNA samples were incubated with the different crude extracts concentrations of E. coli BL21(DE3) harbouring pET22at_axe-txe plasmid (left to right): 0, 1.25, 2.5, 5, 10, 12.5 and 25 µg/ml for 20 min at 220C and analyzed by a native 5% PAGE. Reactions were processed as outlined in Materials and Methods.

https://doi.org/10.1371/journal.pone.0073569.s001

(TIF)

Acknowledgments

We are grateful to Aleksandra Sikora for a gift of pBBRlux plasmid, to Robert Łyżeń for advice on in vitro experiments and a gift of E. coli σ70 RNA polymerase holoenzyme, and to Katarzyna Potrykus for helpful discussions.

Author Contributions

Conceived and designed the experiments: LB GW FH BK. Performed the experiments: LB LL BK. Analyzed the data: LB LL GW FH BK. Wrote the manuscript: BK GW FH.

References

  1. 1. de Kraker MEA, Jarlier V, Monen JCM, Heuer OE, van de Sande N et al. (2012) The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect 19: 860-868. doi:https://doi.org/10.1111/1469-0691.12028.
  2. 2. Kak V, Chow JW (2002) Acquired antibiotic resistance in Enterococci. The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance. Washington, DC: ASM Press. pp. 355–383.
    • 3. Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R et al. (2003) Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299: 2071–2074. doi:https://doi.org/10.1126/science.1080613. PubMed: 12663927.
    • 4. Hayes F (2003) Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301: 1496-1499. doi:https://doi.org/10.1126/science.1088157. PubMed: 12970556.
    • 5. Hayes F, Van Melderen L (2011) Toxins-antitoxins: diversity, evolution and function. Crit Rev Biochem Mol Biol 46: 386-408. doi:https://doi.org/10.3109/10409238.2011.600437. PubMed: 21819231.
    • 6. Schuster CF, Bertram R (2013) Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fate. FEMS Microbiol Lett 340: 73-85. doi:https://doi.org/10.1111/1574-6968.12074. PubMed: 23289536.
    • 7. Gerdes K, Christensen SK, Løbner-Olesen A (2005) Prokaryotic toxin-antitoxin stress response loci. Nat Rev Microbiol 3: 371-382. doi:https://doi.org/10.1038/nrmicro1147. PubMed: 15864262.
    • 8. Bukowski M, Rojowska A, Wladyka B (2011). Prokaryotic toxin-antitoxin systems -the role in bacterial physiology and application in molecular biology. Acta Biochim Pol 58: 1-9.
    • 9. Yamaguchi Y, Park JH, Inouye M (2011). Toxin-antitoxin systems in bacteria and archaea. Annu Rev Genet 45: 61-79.
    • 10. Kędzierska B, Lian LY, Hayes F (2007) Toxin-antitoxin regulation: bimodal interaction of YefM-YoeB with paired DNA palindromes exerts transcriptional autorepression. Nucleic Acids Res 35: 325-339. doi:https://doi.org/10.1093/nar/gkm303. PubMed: 17170003.
    • 11. Overgaard M, Borch J, Gerdes K (2009) RelB and RelE of Escherichia coli form a tight complex that represses transcription via the ribbon-helix-helix motif in RelB. J Mol Biol 394: 183–196. doi:https://doi.org/10.1016/j.jmb.2009.09.006. PubMed: 19747491.
    • 12. Marianovsky I, Aizenman E, Engelberg-Kulka H, Glaser G (2001) The regulation of the Escherichia coli mazEF promoter involves an unusual alternating palindrome. J Biol Chem 276: 5975–5984. doi:https://doi.org/10.1074/jbc.M008832200. PubMed: 11071896.
    • 13. Afif H, Allali N, Couturier M, Van Melderen L (2001) The ratio between CcdA and CcdB modulates the transcriptional repression of the ccd poison-antidote system. Mol Microbiol 41: 73–82. doi:https://doi.org/10.1046/j.1365-2958.2001.02492.x. PubMed: 11454201.
    • 14. Monti MC, Hernández-Arriaga AM, Kamphuis MB, López-Villarejo J, Heck AJ et al. (2007) Interactions of Kid-Kis toxin-antitoxin complexes with the parD operator-promoter region of plasmid R1 are piloted by the Kis antitoxin and tuned by the stoichiometry of Kid-Kis oligomers. Nucleic Acids Res 35: 1737–1749. doi:https://doi.org/10.1093/nar/gkm073. PubMed: 17317682.
    • 15. Overgaard M, Borch J, Jørgensen MG, Gerdes K (2008) Messenger RNA interferase RelE controls relBE transcription by conditional cooperativity. Mol Microbiol 69: 841–857. doi:https://doi.org/10.1111/j.1365-2958.2008.06313.x. PubMed: 18532983.
    • 16. Cataudella I, Trusina A, Sneppen K, Gerdes K, Mitarai N (2012) Conditional cooperativity in toxin-antitoxin regulation prevents random toxin activation and promotes fast translational recovery. Nucleic Acids Res 40: 6424-6434. doi:https://doi.org/10.1093/nar/gks297. PubMed: 22495927.
    • 17. Eberl L, Givskov M, Schwab H (1992) The divergent promoters mediating transcription of the par locus of plasmid RP4 are subject to autoregulation. Mol Microbiol 6: 1969–1979. doi:https://doi.org/10.1111/j.1365-2958.1992.tb01370.x. PubMed: 1508044.
    • 18. Hallez R, Geeraerts D, Sterckx Y, Mine N, Loris R et al. (2010) New toxins homologous to ParE belonging to three component toxin-antitoxin systems in Escherichia coli. Mol Microbiol O157:H7: 76:719–732.
    • 19. de la Hoz AB, Ayora S, Sitkiewicz I, Fernández S, Pankiewicz R et al. (2000) Plasmid copy-number control and better-than-random segregation genes of pSM19035 share a common regulator. Proc Natl Acad Sci U S A 97: 728–733. doi:https://doi.org/10.1073/pnas.97.2.728. PubMed: 10639147.
    • 20. Donegan NP, Cheung AL (2009) Regulation of the mazEF toxin-antitoxin module in Staphylococcus aureus and its impact on sigB expression. J Bacteriol 191: 2795–2805. doi:https://doi.org/10.1128/JB.01713-08. PubMed: 19181798.
    • 21. Mutschler H, Meinhart A (2011). ε/ζ systems: their role in resistance, virulence, and their potential for antibiotic development. J Mol Med. 89:1183-1194.
    • 22. Weaver KE, Jensen KD, Colwell A, Sriram SI (1996) Functional analysis of the Enterococcus faecalis plasmid pAD1-encoded stability determinant par. Mol Microbiol 20: 53-63. doi:https://doi.org/10.1111/j.1365-2958.1996.tb02488.x. PubMed: 8861204.
    • 23. Weaver KE (2012) The par toxin-antitoxin system from Enterococcus faecalis plasmid pAD1 and its chromosomal homologs. RNA Biol 9: 1498-1503. doi:https://doi.org/10.4161/rna.22311. PubMed: 23059908.
    • 24. Grady R, Hayes F (2003) Axe-Txe, a broad-spectrum proteic toxin–antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol Microbiol 47: 1419–1432. doi:https://doi.org/10.1046/j.1365-2958.2003.03387.x. PubMed: 12603745.
    • 25. Greenfield TJ, Franch T, Gerdes K, Weaver KE (2001) Antisense RNA regulation of the par post-segregational killing system: structural analysis and mechanism of binding of the antisense RNA, RNAII and its target, RNAI. Mol Microbiol 42: 527-537. doi:https://doi.org/10.1046/j.1365-2958.2001.02663.x. PubMed: 11703673.
    • 26. Brinkman CL, Bumgarner R, Kittichotirat W, Dunman PM, Kuechenmeister LJ et al. (2013) Characterization of the effects of an rpoC mutation that confers resistance to the Fst peptide toxin-antitoxin system toxin. J Bacteriol 195: 156-166. doi:https://doi.org/10.1128/JB.01597-12. PubMed: 23104812.
    • 27. Halvorsen EM, Williams JJ, Bhimani AJ, Billings EA, Hergenrother PJ (2011) Txe, an endoribonuclease of the enterococcal Axe-Txe toxin-antitoxin system, cleaves mRNA and inhibits protein synthesis. Microbiology 157: 387-397. doi:https://doi.org/10.1099/mic.0.045492-0. PubMed: 21030436.
    • 28. Bjørkeng E, Rasmussen G, Sundsfjord A, Sjöberg L, Hegstad K et al. (2011) Clustering of polyclonal VanB-type vancomycin-resistant Enterococcus faecium in a low-endemic area was associated with CC17-genogroup strains harbouring transferable vanB2-Tn5382 and pRUM-like repA containing plasmids with axe-txe plasmid addiction systems. APMIS 119: 247-242. doi:https://doi.org/10.1111/j.1600-0463.2011.02724.x. PubMed: 21492224.
    • 29. Moritz EM, Hergenrother PJ (2007) Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci. Proc Natl Acad Sci U S A 104: 311-316. doi:https://doi.org/10.1073/pnas.0601168104. PubMed: 17190821.
    • 30. Rosvoll TC, Pedersen T, Sletvold H, Johnsen PJ, Sollid JE et al. (2010) PCR-based plasmid typing in Enterococcus faecium strains reveals widely distributed pRE25-, pRUM-, pIP501- and pHTbeta-related replicons associated with glycopeptide resistance and stabilizing toxin-antitoxin systems. FEMS Immunol Med Microbiol 58: 254-268. doi:https://doi.org/10.1111/j.1574-695X.2009.00633.x. PubMed: 20015231.
    • 31. Christensen SK, Maenhaut-Michel G, Mine N, Gottesman S, Gerdes K et al. (2004) Overproduction of the Lon protease triggers inhibition of translation in Escherichia coli: involvement of the yefM-yoeB toxin-antitoxin system. Mol Microbiol 51: 1705-1717. doi:https://doi.org/10.1046/j.1365-2958.2003.03941.x. PubMed: 15009896.
    • 32. Lenz DH, Mok KC, Lilley BN, Kulkarni RV, Wingreen NS et al. (2004) The small RNA chaperone Hfq and multiple small RNAs control quorum sensing in Vibrio harveyi and Vibrio cholerae. Cell 118: 69–82. doi:https://doi.org/10.1016/j.cell.2004.06.009. PubMed: 15242645.
    • 33. Elliott S, Geiduschek EP (1984) Defining a bacteriophage T4 late promoter: absence of a -35 region, Cell 36:211–219.
      • 34. Bailey SE, Hayes F (2009) Influence of operator site geometry on transcriptional control by the YefM-YoeB toxin-antitoxin complex. J Bacteriol 191: 762-772. doi:https://doi.org/10.1128/JB.01331-08. PubMed: 19028895.
      • 35. Kamada K, Hanaoka F (2005) Conformational change in the catalytic site of the ribonuclease YoeB toxin by YefM antitoxin. Mol Cell 19: 497-509. doi:https://doi.org/10.1016/j.molcel.2005.07.004. PubMed: 16109374.
      • 36. Hayes F (1998) A family of stability determinants in pathogenic bacteria. J Bacteriol 180: 6415-6418. PubMed: 9829958.
      • 37. Silva IJ, Saramago M, Dressaire C, Domingues S, Viegas SC et al. (2011) Importance and key events of prokaryotic RNA decay: the ultimate fate of an RNA molecule. Wiley Interdiscip Rev RNA, 2: 818-836. doi:https://doi.org/10.1002/wrna.94. PubMed: 21976285.
      • 38. Ruiz-Echevarría MJ, de la Cueva G, Díaz-Orejas R (1995) Translational coupling and limited degradation of a polycistronic messenger modulate differential gene expression in the parD stability system of plasmid R1. Mol Gen Genet 248: 599-609. doi:https://doi.org/10.1007/BF02423456. PubMed: 7476860.
      • 39. Prud’homme-Généreux A, Beran RK, Iost I, Ramey CS, Mackie GA et al. (2004) Physical and functional interactions among RNase E, polynucleotide phosphorylase and the cold-shock protein, CsdA: evidence for a ‘cold shock degradosome’. Mol Microbiol 54: 1409–1421. doi:https://doi.org/10.1111/j.1365-2958.2004.04360.x. PubMed: 15554978.
      • 40. Gao J, Lee K, Zhao M, Qiu J, Zhan X et al. (2006) Differential modulation of E. coli mRNA abundance by inhibitory proteins that alter the composition of the degradosome. Mol Microbiol 61: 394–406. doi:https://doi.org/10.1111/j.1365-2958.2006.05246.x. PubMed: 16771842.
      • 41. Jasiecki J, Węgrzyn G (2003) Growth-rate dependent RNA polyadenylation in Escherichia coli. EMBO Rep 4: 172-177. doi:https://doi.org/10.1038/sj.embor.embor733. PubMed: 12612607.
      • 42. Khoo SK, Loll B, Chan WT, Shoeman RL, Ngoo L et al. (2007) Molecular and structural characterization of the PezAT chromosomal toxin-antitoxin system of the human pathogen Streptococcus pneumoniae. J Biol Chem 282: 19606-19618. doi:https://doi.org/10.1074/jbc.M701703200. PubMed: 17488720.
      • 43. Kopfmann S, Hess WR (2013) Toxin-antitoxin systems on the large defense plasmid pSYSA of Synechocystis sp. PCC 6803. J Biol Chem 288: 7399-7409. doi:https://doi.org/10.1074/jbc.M112.434100. PubMed: 23322786.
      • 44. Schuster CF, Park JH, Prax M, Herbig A, Nieselt K et al. (2013) Characterization of a mazEF toxin-antitoxin homologue from Staphylococcus equorum. J Bacteriol 195: 115-125. doi:https://doi.org/10.1128/JB.00400-12. PubMed: 23104807.
      • 45. Sevillano L, Díaz M, Yamaguchi Y, Inouye M, Santamaría RI (2012) Identification of the first functional toxin-antitoxin system in Streptomyces. PLOS ONE. 7: e32977. doi:https://doi.org/10.1371/journal.pone.0032977. PubMed: 22431991.
      • 46. Christensen-Dalsgaard M, Gerdes K (2006) Two higBA loci in the Vibrio cholerae superintegron encode mRNA cleaving enzymes and can stabilize plasmids. Mol Microbiol 62: 397-411. doi:https://doi.org/10.1111/j.1365-2958.2006.05385.x. PubMed: 17020579.